CN109122856A - A kind of liver-protecting sober-up Chinese medicine composition - Google Patents
A kind of liver-protecting sober-up Chinese medicine composition Download PDFInfo
- Publication number
- CN109122856A CN109122856A CN201810721522.9A CN201810721522A CN109122856A CN 109122856 A CN109122856 A CN 109122856A CN 201810721522 A CN201810721522 A CN 201810721522A CN 109122856 A CN109122856 A CN 109122856A
- Authority
- CN
- China
- Prior art keywords
- liver
- grams
- food
- composition
- moringa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 34
- 239000003814 drug Substances 0.000 title abstract description 18
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 29
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 claims abstract description 28
- 244000179886 Moringa oleifera Species 0.000 claims abstract description 26
- 235000011347 Moringa oleifera Nutrition 0.000 claims abstract description 26
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 23
- 244000046052 Phaseolus vulgaris Species 0.000 claims abstract description 22
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims abstract description 22
- 239000000463 material Substances 0.000 claims abstract description 22
- 235000013305 food Nutrition 0.000 claims abstract description 16
- 235000013402 health food Nutrition 0.000 claims abstract description 6
- 239000004615 ingredient Substances 0.000 claims abstract description 5
- 239000000843 powder Substances 0.000 claims description 26
- 235000013336 milk Nutrition 0.000 claims description 12
- 239000008267 milk Substances 0.000 claims description 12
- 210000004080 milk Anatomy 0.000 claims description 12
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 9
- 235000009508 confectionery Nutrition 0.000 claims description 9
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 9
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 9
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 9
- 240000001417 Vigna umbellata Species 0.000 claims description 7
- 235000011453 Vigna umbellata Nutrition 0.000 claims description 7
- 230000036541 health Effects 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 241000723353 Chrysanthemum Species 0.000 claims description 6
- 235000013361 beverage Nutrition 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 239000002778 food additive Substances 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 235000017784 Mespilus germanica Nutrition 0.000 claims description 2
- 244000182216 Mimusops elengi Species 0.000 claims description 2
- 235000000560 Mimusops elengi Nutrition 0.000 claims description 2
- 235000007837 Vangueria infausta Nutrition 0.000 claims description 2
- 235000013373 food additive Nutrition 0.000 claims description 2
- 238000005469 granulation Methods 0.000 claims description 2
- 230000003179 granulation Effects 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 20
- 230000000694 effects Effects 0.000 abstract description 20
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract description 18
- 230000035622 drinking Effects 0.000 abstract description 5
- 230000004060 metabolic process Effects 0.000 abstract description 4
- 230000001133 acceleration Effects 0.000 abstract description 3
- 235000008216 herbs Nutrition 0.000 abstract description 3
- 230000010354 integration Effects 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 229940126678 chinese medicines Drugs 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 15
- 235000019441 ethanol Nutrition 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 239000000047 product Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 239000012153 distilled water Substances 0.000 description 9
- 229940079593 drug Drugs 0.000 description 7
- 239000013612 plasmid Substances 0.000 description 7
- 208000007848 Alcoholism Diseases 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 201000007930 alcohol dependence Diseases 0.000 description 5
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 4
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 4
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 235000002710 Ilex cornuta Nutrition 0.000 description 4
- 241001310146 Ilex cornuta Species 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 244000241838 Lycium barbarum Species 0.000 description 4
- 235000015459 Lycium barbarum Nutrition 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 229960003237 betaine Drugs 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 235000008384 feverfew Nutrition 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- 239000002207 metabolite Substances 0.000 description 4
- 230000001151 other effect Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 244000192528 Chrysanthemum parthenium Species 0.000 description 3
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 3
- 235000015468 Lycium chinense Nutrition 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 2
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 2
- 229930003347 Atropine Natural products 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 108010081577 aldehyde dehydrogenase (NAD(P)+) Proteins 0.000 description 2
- 239000005030 aluminium foil Substances 0.000 description 2
- 230000002075 anti-alcohol Effects 0.000 description 2
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 2
- 229960000396 atropine Drugs 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 229960004756 ethanol Drugs 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 231100000753 hepatic injury Toxicity 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 230000028527 righting reflex Effects 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 201000004647 tinea pedis Diseases 0.000 description 2
- RKUNBYITZUJHSG-FXUDXRNXSA-N (S)-atropine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@H]3CC[C@@H](C2)N3C)=CC=CC=C1 RKUNBYITZUJHSG-FXUDXRNXSA-N 0.000 description 1
- 206010002368 Anger Diseases 0.000 description 1
- 206010003084 Areflexia Diseases 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 description 1
- 244000035851 Chrysanthemum leucanthemum Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 235000007189 Oryza longistaminata Nutrition 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 235000012874 Phaseolus calcaratus Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 1
- 241000219977 Vigna Species 0.000 description 1
- 235000010716 Vigna mungo Nutrition 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001320 aldopentoses Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- SRBFZHDQGSBBOR-QMKXCQHVSA-N alpha-L-arabinopyranose Chemical compound O[C@H]1CO[C@@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-QMKXCQHVSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 239000000883 anti-obesity agent Substances 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940125710 antiobesity agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000003185 calcium uptake Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000000517 effect on sleep Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 229930005342 hyoscyamine Natural products 0.000 description 1
- 229960003210 hyoscyamine Drugs 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229960003284 iron Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000003212 lipotrophic effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/154—Milk preparations; Milk powder or milk powder preparations containing additives containing thickening substances, eggs or cereal preparations; Milk gels
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/156—Flavoured milk preparations ; Addition of fruits, vegetables, sugars, sugar alcohols or sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/18—Milk in dried and compressed or semi-solid form
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/42—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/46—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing dairy products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of liver-protecting sober-up Chinese medicine composition, the composition ingredient includes: four kinds of integration of drinking and medicinal herbs Chinese medicines such as rde bean, fructus lycii, chrysanthemum, leaf of Moringa and a kind of new raw-food material L-arabinose.Liver-protecting sober-up composition of the invention has substantially reduced alcohol to hepar damnification, acceleration of alcohol metabolism, the functions such as Quick sobering.What the present invention used is integration of drinking and medicinal herbs Chinese medicine highly-safe, that toxic side effect is small or new raw-food material, can be developed as products such as ordinary food, health foods.
Description
Technical field
The present invention relates to a kind of food or field of health care products, more particularly, to the food or health care product of liver-protecting sober-up.
Background technique
Drinking is the living habit of Chinese, the necessary beverage of even more various dinner parties;Human body is to the catabolism of alcohol
A kind of normal physiological phenomenon, catabolism is acetic acid under the action of alcohol dehydrogenase and acetaldehyde dehydrogenase in liver in vivo,
Finally it is metabolized as carbon dioxide and water.If human body lacks two kinds of alcohol metabolism enzymes or the vigor of enzyme is not high, liver cannot and
When alcohol is decomposed, especially metabolite acetaldehyde have bigger toxicity, cause body function disorder, cause alcoholism
Phenomenon.
In the mechanism of alcoholic hepatic injury, alcohol and its metabolite acetaldehyde are to the injury of liver, brain and its organ
It is main;Alcoholism has been a worldwide problem, seriously affects the health of majority of populations.
Ancient Times in China has corresponding formula to various alcoholism symptoms there are many good recipe of relieving the effect of alcohol.It is contained according to ancient book, side
Agent is varied, only to the statistics such as Holy Benevolent Prescriptions, " Prescriptions for Universal Relief " and treatise on Febrile Diseases, big and small more than 100 kinds of prescriptions.Previously
The country developed it is a variety of sober up or disintoxicating product such as flower of kudzuvine is waken up the products such as soup for alleviating hangover, Jiu Xianle, Shigao Tang, all have certain shield
Liver is sobered up effect.
L-arabinose, also known as pectinose, arabinose;It is a kind of aldopentose.L-arabinose is seldom in nature
In the form of monosaccharide exist, usually with other monosaccharide ining conjunction with, be present in the form of heteroglycan colloid, hemicellulose, pectic acid, carefully
In granulose and certain glucosides.It is improved people's living condition by food and medicine surveillance authority of the U.S. and Japan as a kind of sweetener low in calories
It saves approval and is included in healthy food additive, representative physiological action is selectively to influence to disappear in small intestine disaccharide-hydrolysing enzymes
The invertase for changing sucrose, to inhibit the absorption of sucrose.American Medical Association is included in the nutritional supplementation for being used as antiobesity agent
Agent or non-prescribed medicine, in the specific health food inventory of Japanese health ministry, L-arabinose is put into for adjusting blood glucose
Dedicated special food supplement.The Ministry of Public Health of China is classified as new resource food in May, 2008.L-arabinose pair
Enteron aisle can play good acidizing effect, and intestinal acidity environmental benefits are in Bifidobacterium, the life of the intestine beneficial bacteria colonies such as lactic acid bacteria
It is long, promote body to calcium uptake, enhance the ability of body discharge Toxic, inhibits harmful microorganism proliferation, to enhance human body
Resistance.
Rde bean, alias: red bean, red rice bean, rice bean, albumen beans, Chi Shandou, Latin literary fame: Vigna umbellata
(Thunb.) Ohwi et Ohashi is beans annual herb.Rde bean is mainly used for Chinese medicine, often mixed with red bean, has benefit
Water detumescence section, Vigna, removing toxic substances apocenosis and other effects.Rde bean contain protein, fat, carbohydrate, crude fibre, calcium, phosphorus,
The nutritional ingredients such as iron, vitamin B1, vitamin B2, saponin(e.Its nutritive effect: it is mild-natured, it is sweet in flavor, sour, energy is inducing diuresis and reducing edema (oedema,
Tinea pedis, jaundice, dysentery, hematochezia, carbuncle swells), heat-clearing removing jaundice, removing toxic substances apocenosis.With good relax bowel and defecation, lowering blood pressure and blood fat,
The effects of adjusting blood glucose, prevention calculus, body building and weight reducing.
Leaf of Moringa refers to the leaf for originating in the perennial tropical deciduous tree Moringa tree (also known as drumstick tree) of India, edible
With, with supplementing the nutrients comprehensively, immunity is improved, toxin-expelling and face nourishing, logical intestines are convenient, lose weight and other effects.Leaf of Moringa powder is full of nutrition
And it is comprehensive, vitamin E is 70 times and 40 times of spirulina and soybean powder respectively.Leaf of Moringa powder has hypoglycemic, lipid-loweringing, decompression, resists
Tumour, anti-oxidant, defaecation, diuresis, expelling parasite, improvement sleep and other effects, long-term consumption can enhance immune function of human body, delay to decline
Always, prevent disease.Ayurveda thinks that Moringa can prevent 300 kinds of diseases.Especially in recent years Moringa by prosperities such as America and Europes
The concern of national many research institutions and consumer and heat are held in both hands.
This title of fructus lycii is first appeared in " Book of Songs " before Chinese two thousand years.Drug scholar's Li Shizhen (1518-1593 A.D.) cloud of the Ming Dynasty: " Chinese holly
Qi, two tree names.The thorn of this object spine such as Chinese holly, the item of stem such as Qi, therefore and name it." fruit (Chinese medicine claims fructus lycii), main ingredient: Chinese holly
Matrimony vine (betane) containing glycine betaine, atropine (atropine), hyoscyamine (gyoscyamine).Polysaccharides is a kind of water
Soluble polysaccharide is most important active constituent in fructus lycii.It there is now a lot research shows that polysaccharides has promotion immune, anti-ageing
Always, the effects of antitumor, removing free radical, antifatigue, anti-radiation, liver protection, reproductive function protection and improvement.Glycine betaine: chemistry
Entitled 1- carboxy-N, N, N- betaine is similar to amino acid in chemical structure, belongs to quaternary amine alkaloids.
Fructus lycii is mainly due to caused by contained glycine betaine to lipid-metabolism or lipotropic effect, it plays methyl supply in vivo
The effect of body.Wolfberry pigment: wolfberry pigment is all kinds of present-color materials being present in fructus lycii berry, is the important physiology of fructus lycii seed
Active constituent.Main includes-carrotene, lutein and other coloring matters.Carotenoid contained by fructus lycii then has non-
Often important medical value.Verified fructus lycii seed pigment has raising immune function of human body, prevention and inhibits swollen for many researchs
The effects of tumor and prevention of arterial atherosis.
Chrysanthemum (Classification system: Dendranthema morifolium (Ramat.) Tzvel.): it is in Plant Taxonomy
Composite family, Chrysanthemum perennial herb plant.Feverfew property is pungent, sweet, bitter, slightly cold.Return lung, Liver Channel.Effect dispelling wind and heat from the body is put down
Liver improving eyesight, it is clearing heat and detoxicating.For anemopyretic cold, fever and headache, red eyes and dim-sighted, kidney deficiency and liver, mesh is secretly dim-sighted, and dizziness infantile convulsion is controlled
Liver-yang hyperactivity, headache and dizziness are apt to dispelling wind and heat, clearing liver-fire, and energy benefiting yin improving eyesight, therefore can be used and control in wind-heat of liver channel or irascibility
Caused red eye, swell pain is attacked, the benefits of long memorial wind clears liver and improve vision is total to;It is clearing heat and detoxicating, outstanding kind solution serious case of furuncle, therefore can be used and control furuncle swelling toxin.
Chinese patent CN101797023A discloses application of the L-arabinose as Medicament for Alcoholism, finds it in research process
The activity of alcohol dehydrogenase and acetaldehyde dehydrogenase, acceleration of alcohol metabolic process, when alleviation alcohol is put aside in human body can be enhanced
Between long cause harm to the human body.
Chinese patent CN102058047A discloses a kind of guarantor of alleviation alcoholic liver being made of L-arabinose, Mixed Microbes
Health food innovatively combines L-arabinose, Mixed Microbes, solves in Antialcoholic liver-protecting health care product in the prior art and solve bartender
The effect of liver not prominent question.But Mixed Microbes are added in the technical solution, it is especially high to manufacturing technique requirent, and to product matter
Amount requirement is also relatively high, and product needs low-temperature storage, shelf-life short, increases cost indirectly.
Chinese patent CN201510154071 discloses a kind of composition of protect liver restoring consciouness, mainly by L-arabinose and Chinese holly
The effect of Qi chrysanthemum is combined, and reaches liver protection and eyesight, and restoring consciouness is detoxified, has certain characteristic and advantage.But its diuresis effect compared with
Difference, alcohol and its metabolite drainage difficulty, it may appear that some side reactions.
Object of the present invention is to advanced optimize formula combination on the basis of L-arabinose, fructus lycii, chrysanthemum composition, increase
Its inducing diuresis and reducing edema (oedema, tinea pedis, jaundice, dysentery, hematochezia, carbuncle swells), heat-clearing removing jaundice, removing toxic substances apocenosis, extra-nutrition, raising is added to exempt from
It is convenient and other effects to lead to intestines for epidemic disease power.It is screened by a large amount of zooperies, discovery the composition has more preferably superior liver-protecting sober-up function
Effect, and side reaction is less.
Summary of the invention
In order to overcome the shortcomings of L-arabinose, the fructus lycii, chrysanthemum composition of prior inventions, inventor passes through a large amount of animals
Experiment screening, it was found that a kind of new composition has preferably synergistic effect, can not only improve alcohol metabolism enzyme degradation wine
Essence can be reduced alcohol residence time in vivo, be substantially reduced alcohol and its generation with the excretion of acceleration of alcohol and its metabolite
Thank to product to hepar damnification.The raw material that the present invention uses is new raw-food material or integration of drinking and medicinal herbs material, and safety is good, Ke Yichang
Phase is edible.
The present invention provides a kind of composition of liver-protecting sober-up, includes following component: L-arabinose according to mass percent
10-45%, rde bean 10-30%, leaf of Moringa 10-20%, fructus lycii 5-25%, chrysanthemum 5-25%;
It preferably, include following component: L-arabinose 20-40%, rde bean 20-30% according to mass percent meter,
Leaf of Moringa 10-20%, fructus lycii 10-20%, chrysanthemum 10-20%;
It is furthermore preferred that including following component: L-arabinose 30-44%, rde bean 20- according to mass percent meter
25%, leaf of Moringa 15-20%, fructus lycii 15-20%, chrysanthemum 15-20%.
Liver-protecting sober-up composition provided by the invention can also be added protection gastric mucosa and correct the milk powder of bitter taste.
Preferably, the mass percent of the milk powder in the composition are as follows: 0-20% is more selected as 15-20%.
Liver-protecting sober-up composition provided by the invention, also include common food auxiliary material and food additives, food auxiliary material and
Mass percent 10-20% shared by additive, preferably 15-20%.
Liver-protecting sober-up composition provided by the invention, the tablet are prepared by the following method: L-arabinose 100-400
Gram, 0-300 grams of red bean powder, 0-300 grams of leaf of Moringa powder, 50-250 grams of medlar powder, 50-250 grams of chrysanthemum powder, milk powder 100-
200 grams, 100-200 grams of microcrystalline cellulose;Through mixing granulation, the tablet or pressed candy is made in tabletting machine.
The present invention also provides a kind of liver-protecting sober-up compositions to apply in the food or health care product for preparing liver-protecting sober-up.
Agents useful for same and raw material are commercially available available in the present invention.
Except other explanation, rde bean of the present invention includes rde bean medicinal material, the prepared slices of Chinese crude drugs, red bean powder or its extraction
Object;The leaf of Moringa includes leaf of Moringa medicinal material, the prepared slices of Chinese crude drugs, leaf of Moringa powder or its extract;The fructus lycii include medicinal material,
The prepared slices of Chinese crude drugs, wolfberry fruit powder and its extract;The chrysanthemum is that feverfew includes feverfew medicinal material, the prepared slices of Chinese crude drugs, feverfew pollen
And its extract.
The positive effect of the present invention is that: not only rationality designs liver-protecting sober-up composition provided by the invention, also
There are a large amount of zoopery garbled datas, it was demonstrated that its synergistic action effect is good;Not only medicinal material is raw-food material, and safety is good, matches
Side is also fairly simple, is easy to quality control, it is important to can reach more relieving alcoholism and protecting liver effect.
Specific embodiment
The present invention is further illustrated below by embodiment, but not therefore only invention is limited in scope of embodiments, under
Experimental method is not specified in the embodiment of face is routine experiment method, is operated according to product manual.
The embodiment of liver-protecting sober-up Chinese medicine composition:
The prescription of 1 embodiment 1-7 of table
Embodiment 1
Weigh 100 grams of L-arabinose, 300 grams of rde bean, 100 grams of leaf of Moringa, 100 grams of fructus lycii, 100 grams of chrysanthemum, milk powder
200 grams and 100 grams of microcrystalline cellulose, 40 meshes are crossed respectively, and above-mentioned material addition plasmid pot is uniformly mixed.With capsule filler
No. 0 capsule of encapsulating, that is, be made capsule.
Embodiment 2
Weigh 200 grams of L-arabinose, 300 grams of rde bean, 100 grams of leaf of Moringa, 150 grams of fructus lycii, 50 grams of chrysanthemum, milk powder
100 grams and 100 grams of microcrystalline cellulose, 40 meshes are crossed respectively, and above-mentioned material addition plasmid pot is uniformly mixed.Aluminium foil bag dispenses
Obtain solid beverage.
Embodiment 3
Weigh 300 grams of L-arabinose, 200 grams of rde bean, 100 grams of leaf of Moringa, 100 grams of fructus lycii, 100 grams of chrysanthemum, milk powder
100 grams and 100 grams of microcrystalline cellulose, 40 meshes are crossed respectively, and above-mentioned material addition plasmid pot is uniformly mixed.Aluminium foil bag dispenses
Obtain solid beverage.
Embodiment 4
Weigh 200 grams of L-arabinose, 100 grams of rde bean, 200 grams of leaf of Moringa, 50 grams of fructus lycii, 200 grams of chrysanthemum, milk powder
100 grams and 150 grams of microcrystalline cellulose, 40 meshes are crossed respectively, and above-mentioned material addition plasmid pot is uniformly mixed.Through tabletting machine
Up to tablet.
Embodiment 5
Weigh 400 grams of L-arabinose, 100 grams of rde bean, 100 grams of leaf of Moringa, 250 grams of fructus lycii, 50 grams of chrysanthemum, milk powder 0
Gram and 100 grams of microcrystalline cellulose, respectively cross 40 meshes, by above-mentioned material addition plasmid pot be uniformly mixed.Through tablet press machine large size mould
Has tabletting up to pressed candy.
Embodiment 6
Weigh 400 grams of L-arabinose, 100 grams of rde bean, 100 grams of leaf of Moringa, 250 grams of fructus lycii, 50 grams of chrysanthemum, milk powder 0
Gram and 100 grams of microcrystalline cellulose, respectively cross 40 meshes, by above-mentioned material addition plasmid pot be uniformly mixed.Through tablet press machine large size mould
Has tabletting up to pressed candy.
Embodiment 7
Weigh 400 grams of L-arabinose, 0 gram of rde bean, 0 gram of leaf of Moringa, 150 grams of fructus lycii, 150 grams of chrysanthemum, 100 grams of milk powder
With 200 grams of microcrystalline cellulose, respectively cross 40 meshes, by above-mentioned material addition plasmid pot be uniformly mixed.Through tablet press machine large size mould
Tabletting is up to pressed candy.
Embodiment 8: liver-protecting sober-up effect test
Below by way of mouse test, liver-protecting sober-up effect is carried out to the sample of embodiment 1-7 and is evaluated,
Drug and reagent
L-arabinose, dehydrated alcohol (analyze pure, Sinopharm Chemical Reagent Co., Ltd.), commercially.
Test composition is prepared respectively according to embodiment 1-7
Experimental animal:
ICR mouse, animal rank: cleaning grade is provided by Shanghai western Poole-Bi Kai experimental animal Co., Ltd
Dose design and give drug solns prepare:
Control group: 0.95 gram of L-arabinose is weighed, distilled water is added to be configured to 7.5ml aqueous solution
Administration group 1: 0.95 gram of example 1 group mixture is weighed, distilled water is added to be configured to 7.5ml solution
Administration group 2: 2 groups of embodiment, 0.95 gram of mixture is weighed, distilled water is added to be configured to 7.5ml solution
Administration group 3: 3 groups of embodiment, 0.95 gram of mixture is weighed, distilled water is added to be configured to 7.5ml solution
Administration group 4: 4 groups of embodiment, 0.95 gram of mixture is weighed, distilled water is added to be configured to 7.5ml solution
Administration group 5: 5 groups of embodiment, 0.95 gram of mixture is weighed, distilled water is added to be configured to 7.5ml solution
Administration group 6: 6 groups of embodiment, 0.95 gram of mixture is weighed, distilled water is added to be configured to 7.5ml solution
Administration group 7: 7 groups of embodiment, 0.95 gram of mixture is weighed, distilled water is added to be configured to 7.5ml solution
Male ICR mouse 90 of 19-20 grams of weight are taken, random point 9 groups, every group 10, respectively model group, control
Group, administration 1-7 group.After mouse is deprived of food but not water 12 hours, model group stomach-filling distilled water, other groups give corresponding medical fluid, stomach-filling
0.2ml/10 grams of volume.After 30 minutes, 50% ethanol solution of each group intragastric administration on mice (0.16ml/10 grams).Mouse is recorded to after drinking
To there is righting reflex loss (i.e. drunk time);Righting reflex restores (sobering up the time), compares each group mice drunk and sobers up
Situation.
The different prescription mice drunks of table 2 and situation of sobering up
Group | Number of animals (only) | Drunk time (min) | Sober up the time (min) |
Model group | 10 | 14.85±12.56 | 280.00±30.75 |
Control group | 10 | 19.35±14.51 | 235.12±35.35 |
It is administered 1 group | 10 | 28.25±14.16 | 201.10±25.15 |
It is administered 2 groups | 10 | 31.35±13.52 | 197.05±12.34 |
It is administered 3 groups | 10 | 32.85±17.32 | 185.12±18.24 |
It is administered 4 groups | 10 | 35.85±14.22 | 180.00±24.14 |
It is administered 5 groups | 10 | 39.26±13.56 | 177.15±22.25 |
It is administered 6 groups | 10 | 42.45±16.26 | 170.12±19.35 |
It is administered 7 groups | 10 | 27.45±11.36 | 210.00±25.71 |
Can be seen that administration 1-7 group according to the above experimental data has protection to a certain degree to make hepatic injury caused by ethyl alcohol
With shortening is sobered up the time, has anti-alcohol function;It is good that 1-6 group compares L-arabinose control group effect, also compares L- Arab
Sugar, fructus lycii chrysanthemum group effect are good.Therefore, new Chinese medicine composition has the function of more preferably liver-protecting sober-up.
Claims (9)
1. a kind of liver-protecting sober-up composition, which is characterized in that include following ingredient: L-arabinose 10- according to mass percent
45%, rde bean 10-30%, leaf of Moringa 10-30%, fructus lycii 5-25%, chrysanthemum 5-25%.
2. liver-protecting sober-up composition as described in claim 1 includes following ingredient: L-arabinose 20- according to mass percent
40%, rde bean 20-30%, leaf of Moringa 10-20%, fructus lycii 10-20%, chrysanthemum 10-20%.
3. liver-protecting sober-up composition as described in claim 1 includes following ingredient: L-arabinose according to mass percent
30-40%, rde bean 20-25%, leaf of Moringa 15-20%, fructus lycii 15-20%, chrysanthemum 15-20%.
4. liver-protecting sober-up composition a method according to any one of claims 1-3, it is characterised in that also contain milk powder, according to quality percentage
Than including 0-20%, preferably 15-20%.
5. the liver-protecting sober-up composition as described in claim 1-4 is any, it is characterised in that also added containing food auxiliary material or food
Agent.
6. the liver-protecting sober-up composition as described in claim 1-5 is any, it is characterised in that contained food auxiliary material or food additives
Shared mass percent 10-20%, preferably 15-20%.
7. a kind of use composition as claimed in any one of claims 1 to 6 to eat for the food of liver-protecting sober-up made of raw material or health care
Product.
8. food as claimed in claim 7 or health food, the food or health food can be solid beverage, tablet,
Capsule or pressed candy.
9. food as claimed in claim 8 or health food, the tablet or pressed candy are prepared by the following method: L- I
100-400 grams of uncle's sugar, 100-300 grams of red bean powder, 100-300 grams of leaf of Moringa powder, 50-250 grams of medlar powder, chrysanthemum powder 50-
250 grams, 0-200 grams of milk powder, 100-200 grams of microcrystalline cellulose;Through mixing granulation, the tablet or pressure is made in tabletting machine
Piece candy.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810721522.9A CN109122856A (en) | 2018-07-05 | 2018-07-05 | A kind of liver-protecting sober-up Chinese medicine composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810721522.9A CN109122856A (en) | 2018-07-05 | 2018-07-05 | A kind of liver-protecting sober-up Chinese medicine composition |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109122856A true CN109122856A (en) | 2019-01-04 |
Family
ID=64799886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810721522.9A Pending CN109122856A (en) | 2018-07-05 | 2018-07-05 | A kind of liver-protecting sober-up Chinese medicine composition |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109122856A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111686236A (en) * | 2020-07-15 | 2020-09-22 | 碧豫药业有限责任公司 | Capsule for relieving alcoholism and protecting liver and brain |
CN113693214A (en) * | 2021-07-14 | 2021-11-26 | 西藏名承坤泰生物科技有限公司 | Tomato and medlar moringa oleifera powder and preparation method thereof |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040132816A1 (en) * | 2003-01-06 | 2004-07-08 | Liao Medical Corporation | Lipid metabolism and fructus crataegus |
CN101797279A (en) * | 2009-11-26 | 2010-08-11 | 济南圣泉唐和唐生物科技有限公司 | Health care product with dealcoholic function |
CN102578671A (en) * | 2012-03-20 | 2012-07-18 | 牟一心 | Alcoholism-relieving liver-protecting botanical nutritional beverage and making method thereof |
CN103285252A (en) * | 2012-12-27 | 2013-09-11 | 福建永生活力生物工程有限公司 | Oral liquid for alleviating hangover and protecting liver, and preparation method thereof |
CN103860937A (en) * | 2014-03-24 | 2014-06-18 | 重庆三峡医药高等专科学校 | Traditional Chinese medicine with function of chemical liver injury and application of traditional Chinese medicine |
CN104783031A (en) * | 2015-04-02 | 2015-07-22 | 国药集团健康产业研究院有限公司 | Composition capable of protecting liver and brain |
CN105614851A (en) * | 2015-12-27 | 2016-06-01 | 劲膳美生物科技股份有限公司 | Medical formula food for hepatic encephalopathy |
CN106215094A (en) * | 2016-07-29 | 2016-12-14 | 赵冰丽 | A kind of relieving alcoholism and protecting the liver health product and preparation method thereof |
-
2018
- 2018-07-05 CN CN201810721522.9A patent/CN109122856A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040132816A1 (en) * | 2003-01-06 | 2004-07-08 | Liao Medical Corporation | Lipid metabolism and fructus crataegus |
CN101797279A (en) * | 2009-11-26 | 2010-08-11 | 济南圣泉唐和唐生物科技有限公司 | Health care product with dealcoholic function |
CN102578671A (en) * | 2012-03-20 | 2012-07-18 | 牟一心 | Alcoholism-relieving liver-protecting botanical nutritional beverage and making method thereof |
CN103285252A (en) * | 2012-12-27 | 2013-09-11 | 福建永生活力生物工程有限公司 | Oral liquid for alleviating hangover and protecting liver, and preparation method thereof |
CN103860937A (en) * | 2014-03-24 | 2014-06-18 | 重庆三峡医药高等专科学校 | Traditional Chinese medicine with function of chemical liver injury and application of traditional Chinese medicine |
CN104783031A (en) * | 2015-04-02 | 2015-07-22 | 国药集团健康产业研究院有限公司 | Composition capable of protecting liver and brain |
CN105614851A (en) * | 2015-12-27 | 2016-06-01 | 劲膳美生物科技股份有限公司 | Medical formula food for hepatic encephalopathy |
CN106215094A (en) * | 2016-07-29 | 2016-12-14 | 赵冰丽 | A kind of relieving alcoholism and protecting the liver health product and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
云南省餐饮与美食行业协会: "《滇香四溢》", 31 August 2016, 云南科技出版社 * |
刘博纯等: "《解酒食谱》", 28 February 1999, 辽宁大学出版社 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111686236A (en) * | 2020-07-15 | 2020-09-22 | 碧豫药业有限责任公司 | Capsule for relieving alcoholism and protecting liver and brain |
CN111686236B (en) * | 2020-07-15 | 2023-07-14 | 碧豫药业有限责任公司 | Capsule for dispelling effects of alcohol, protecting liver and protecting brain |
CN113693214A (en) * | 2021-07-14 | 2021-11-26 | 西藏名承坤泰生物科技有限公司 | Tomato and medlar moringa oleifera powder and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107114783B (en) | High-selenium nutritional supplement for enhancing immunity and assisting tumor recovery | |
CN103054113B (en) | Composite fruit-vegetable juice beverage with blood sugar decreasing effect | |
CN106983052A (en) | A kind of solid beverage of auxiliary hyperglycemic and preparation method thereof | |
CN106666312A (en) | Health-care food for assisting blood glucose decreasing and preparation method of granule and capsule thereof | |
CN102827750A (en) | Maca health care liquor for improving organism immunity and sexuality | |
CN107050148B (en) | Traditional Chinese medicine composition for dispelling effects of alcohol and protecting liver and preparation method thereof | |
CN106261439A (en) | Protein Diets fiber meal replacement powder and preparation method | |
CN104432035B (en) | The health nutrient composition and method of making the same of enhancing immunity and application | |
CN108014150B (en) | Application of natural medicine composition in preparing anti-hypoxia and anti-radiation medicine or food | |
CN114128813A (en) | Beverage for relieving alcoholism and protecting liver and promoting vitality of liver and preparation method thereof | |
CN106723015A (en) | A kind of health food and its preparation technology with antifatigue and anti-oxidation function | |
WO2021047217A1 (en) | Immunity-enhancing composition, beverage, and preparation method therefor | |
CN109122856A (en) | A kind of liver-protecting sober-up Chinese medicine composition | |
CN101711840B (en) | Medicine-food dual-purpose composition suitable for cancerous patients and preparation method thereof | |
CN112913957A (en) | Liver-protecting sargassum salina tablet candy and preparation method thereof | |
CN103725555A (en) | Wild banana and oxhorn banana health-care wine for assisting blood pressure reduction and preparation method thereof | |
CN107787191B (en) | Composition for weight loss comprising a beverage and beads | |
CN108576346A (en) | A kind of Inonotus obliquus pressed candy of energy anticancer reducing pressure and sugar reducing blood lipid | |
CN104783031B (en) | A kind of protect liver protects brain composition | |
CN111357891A (en) | Plant beverage containing artichoke and ginseng and preparation method thereof | |
CN107836619A (en) | A kind of beautiful millettia root solid beverage with strengthen immunity and antifatigue effect and preparation method thereof | |
CN101955874B (en) | Method for brewing bitter almond liqueur | |
CN106912940A (en) | A kind of composition containing L-arabinose and application thereof | |
CN103920140B (en) | A kind of people is with blood sugar lowering Weight-reducing and lipid-lowering compound preparation | |
CN106912920A (en) | A kind of composition containing mulberry-leaf extract and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190104 |
|
RJ01 | Rejection of invention patent application after publication |